End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
- PTS | -.--% |
|
-.--% | -.--% |
Summary
- The company presents an interesting fundamental situation from a short-term investment perspective.
Strengths
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- The group's high margin levels account for strong profits.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
- Over the past twelve months, analysts' opinions have been strongly revised upwards.
- Considering the small differences between the analysts' various estimates, the group's business visibility is good.
- Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
Weaknesses
- With relatively low growth outlooks, the group is not among those with the highest revenue growth potential.
- With a 2024 P/E ratio at 26.99 times the estimated earnings, the company operates at rather significant levels of earnings multiples.
- With an enterprise value anticipated at 4.21 times the sales for the current fiscal year, the company turns out to be overvalued.
- In relation to the value of its tangible assets, the company's valuation appears relatively high.
Ratings chart - Surperformance
Sector: Personal Products
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-.--% | 77.74B | - | ||
+13.56% | 393B | C- | ||
+16.49% | 141B | B- | ||
-21.99% | 40.91B | B+ | ||
+7.48% | 35.01B | B- | ||
-16.26% | 34.52B | - | ||
+11.92% | 18.75B | A- | ||
+23.46% | 17.25B | B | ||
+9.44% | 12.93B | C+ | ||
+16.43% | 9.57B | B |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- CL Stock
- COLGA Stock
- Ratings Colgate-Palmolive